Galectin TherapeuticsGALT 
$2.771.84%24h
1.84%24h
Global rank18275
Market cap$171.32M
Change 7d17.37%
YTD Performance64.88%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of Galectin Therapeutics (GALT)
As of November 2024, Galectin Therapeutics has a market cap of $171.32M. This makes Galectin Therapeutics the world's 18275th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Galectin Therapeutics from 2002 to 2024
-
Value:-
Market cap history of Galectin Therapeutics from 2002 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $108.42M | 5.60% |
| 2023 | $102.67M | 46.90% |
| 2022 | $69.89M | -45.41% |
| 2021 | $128.03M | -7.59% |
| 2020 | $138.54M | -21.68% |
| 2019 | $176.89M | -16.62% |
| 2018 | $212.14M | 2.69% |
| 2017 | $206.57M | 240.82% |
| 2016 | $60.61M | -40.24% |
| 2015 | $101.43M | -52.74% |
| 2014 | $214.61M | -57.05% |
| 2013 | $499.74M | 294.15% |
| 2012 | $126.79M | -64.41% |
| 2011 | $356.25M | 6.67% |
| 2010 | $333.98M | 221.43% |
| 2009 | $103.91M | 211.11% |
| 2008 | $33.40M | -87.14% |
| 2007 | $259.76M | 55.56% |
| 2006 | $166.99M | -85.25% |
| 2005 | $1.13B | 22.00% |
| 2004 | $927.73M | -36.71% |
| 2003 | $1.47B | 36.21% |
| 2002 | $1.08B | - |
GALT Market Cap Today is $171.32M 1.84% - 1 Nov 2024
View largest stocks by market cap 
